Cite

MLA Citation

    A Snir et al.. “Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.” Annals of the rheumatic diseases, vol. 70, n.d., pp. A57–A58. http://access.bl.uk/ark:/81055/vdc_100137792441.0x000060
  
Back to record